Abstract
We determined the prevalence of incidental extracardiac findings (IEF) at Magnetic Resonance Imaging (MRI) potentially related to anemia and hypoxia in age- and sex-matched populations (N = 318) with thalassemia major (TM) and thalassemia intermedia (TI) enrolled in the Myocardial Iron Overload in Thalassemia network. Overall, IEFs were detected in 33.3% and 25.8% of patients with TI and TM, respectively (P = 0.114). TI and TM patients had elevated but comparable prevalence of renal, splenic and liver cysts, and vertebral hemangiomas while TI patients had a significant higher frequency of extramedullary hematopoiesis (EMH) (15.1% vs 4.4%; P = 0.002). The prevalence of total IEFs increased with advancing age. TI non-transfusion-dependent patients had a significantly lower frequency of renal cysts than TI transfusion-dependent patients (8.8% vs 26.4%; P = 0.005). The prevalence of renal cysts in the thalassemic population was significantly higher than that in the general population (19.2% vs 1.9%; P < 0.0001). Our data on renal cysts indicate a significant higher prevalence of these IEFs compared to the general population, suggesting the role of the inappropriate activation of the hypoxia-inducible factor system linked to the chronic hypoxia. The significant prevalence of IEF in thalassemia patients undergoing MRI for iron quantification should prompt the discussion of the inclusion of IEF in the MRI report.
Similar content being viewed by others
References
Mavrogeni S, Pepe A, Lombardi M (2011) Evaluation of myocardial iron overload using cardiovascular magnetic resonance imaging. Hell J Cardiol 52(5):385–390
Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ (2008) Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 10(1):42
Pepe A, Meloni A, Rossi G, Midiri M, Missere M, Valeri G, Sorrentino F, D'Ascola DG, Spasiano A, Filosa A, Cuccia L, Dello Iacono N, Forni G, Caruso V, Maggio A, Pitrolo L, Peluso A, De Marchi D, Positano V, Wood JC (2017) Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach. Eur Heart J Cardiovasc Imaging 19(3):299–309
Dewey M, Schnapauff D, Teige F, Hamm B (2007) Non-cardiac findings on coronary computed tomography and magnetic resonance imaging. Eur Radiol 17(8):2038–2043
McKenna DA, Laxpati M, Colletti PM (2008) The prevalence of incidental findings at cardiac MRI. Open Cardiovasc Med J 2:20–25
Vogel-Claussen J, Li D, Carr J, Liu K, Szklo M, Lima JA, Bluemke DA (2009) Extracoronary abnormalities on coronary magnetic resonance angiography in the multiethnic study of atherosclerosis study: frequency and clinical significance. J Comput Assist Tomogr 33(5):752–754
Sohns JM, Schwarz A, Menke J, Staab W, Spiro JE, Lotz J, Unterberg-Buchwald C (2014) Prevalence and clinical relevance of extracardiac findings at cardiac MRI. J Magn Reson Imaging 39(1):68–76
Ricchi P, Meloni A, Spasiano A, Neri MG, Gamberini MR, Cuccia L, Caruso V, Gerardi C, D'Ascola DG, Rosso R, Campisi S, Rizzo M, Terrazzino F, Vangosa AB, Chiodi E, Missere M, Mangione M, Positano V, Pepe A (2015) Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients. Am J Hematol 90(11):1008–1012
Ricchi P (2017) Extramedullary haematopoiesis in patients with thalassaemia major: should we search for it regularly? Acta Haematol 137(3):173–174
Cao A, Galanello R (2010) Beta-thalassemia. Genet Med 12(2):61–76
Gardenghi S, Grady RW, Rivella S (2010) Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in beta-thalassemia. Hematol Oncol Clin North Am 24(6):1089–1107
Tanno T, Miller JL (2010) Iron loading and overloading due to ineffective erythropoiesis. Adv Hematol 2010:358283
Ferro E, Visalli G, Curro M, La Rosa MA, Piraino B, Salpietro C, Di Pietro A (2016) HIF1alpha and Glut1 receptor in transfused and untransfused thalassemic patients. Br J Haematol 174(5):824–826
Findeis-Hosey JJ, McMahon KQ, Findeis SK (2016) Von Hippel-Lindau disease. J Pediatr Genet 5(2):116–123
Gordeuk VR, Sergueeva AI, Miasnikova GY, Okhotin D, Voloshin Y, Choyke PL, Butman JA, Jedlickova K, Prchal JT, Polyakova LA (2004) Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 103(10):3924–3932
Ricchi P, Ammirabile M, Spasiano A, Costantini S, Di Matola T, Carteni G, Filosa A, Cinque P (2014) Renal cell carcinoma in adult patients with thalassaemia major: a description of three cases. Br J Haematol 165(6):887–888
Meloni A, Ramazzotti A, Positano V, Salvatori C, Mangione M, Marcheschi P, Favilli B, De Marchi D, Prato S, Pepe A, Sallustio G, Centra M, Santarelli MF, Lombardi M, Landini L (2009) Evaluation of a web-based network for reproducible T2* MRI assessment of iron overload in thalassemia. Int J Med Inform 78(8):503–512
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470
Pepe A, Positano V, Santarelli F, Sorrentino F, Cracolici E, De Marchi D, Maggio A, Midiri M, Landini L, Lombardi M (2006) Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload. J Magn Reson Imaging 23(5):662–668
Meloni A, Positano V, Pepe A, Rossi G, Dell'Amico M, Salvatori C, Keilberg P, Filosa A, Sallustio G, Midiri M, D'Ascola D, Santarelli MF, Lombardi M (2010) Preferential patterns of myocardial iron overload by multislice multiecho T*2 CMR in thalassemia major patients. Magn Reson Med 64(1):211–219
Pepe A, Positano V, Capra M, Maggio A, Lo Pinto C, Spasiano A, Forni G, Derchi G, Favilli B, Rossi G, Cracolici E, Midiri M, Lombardi M (2009) Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major. Heart 95:1688–1693
Positano V, Salani B, Pepe A, Santarelli MF, De Marchi D, Ramazzotti A, Favilli B, Cracolici E, Midiri M, Cianciulli P, Lombardi M, Landini L (2009) Improved T2* assessment in liver iron overload by magnetic resonance imaging. Magn Reson Imaging 27(2):188–197
Meloni A, Luciani A, Positano V, De Marchi D, Valeri G, Restaino G, Cracolici E, Caruso V, Dell'amico MC, Favilli B, Lombardi M, Pepe A (2011) Single region of interest versus multislice T2* MRI approach for the quantification of hepatic iron overload. J Magn Reson Imaging 33(2):348–355
Meloni A, Rienhoff HY Jr, Jones A, Pepe A, Lombardi M, Wood JC (2013) The use of appropriate calibration curves corrects for systematic differences in liver R2* values measured using different software packages. Br J Haematol 161(6):888–891
Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106(4):1460–1465
Habib G, Bucciarelli-Ducci C, Caforio ALP, Cardim N, Charron P, Cosyns B, Dehaene A, Derumeaux G, Donal E, Dweck MR, Edvardsen T, Erba PA, Ernande L, Gaemperli O, Galderisi M, Grapsa J, Jacquier A, Klingel K, Lancellotti P, Neglia D, Pepe A, Perrone-Filardi P, Petersen SE, Plein S, Popescu BA, Reant P, Sade LE, Salaun E, Slart R, Tribouilloy C, Zamorano J (2017) Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document in collaboration with the “working group on myocardial and pericardial diseases” of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography. Eur Heart J Cardiovasc Imaging 18(10):1090–1121
Wood JC (2007) Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol 14(3):183–190
Pennell DJ, Udelson JE, Arai AE, Bozkurt B, Cohen AR, Galanello R, Hoffman TM, Kiernan MS, Lerakis S, Piga A, Porter JB, Walker JM, Wood J (2013) Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association. Circulation 128(3):281–308
Meloni A, Positano V, Ruffo GB, Spasiano A, D'Ascola DG, Peluso A, Keilberg P, Restaino G, Valeri G, Renne S, Midiri M, Pepe A (2015) Improvement of heart iron with preserved patterns of iron store by CMR-guided chelation therapy. Eur Heart J Cardiovasc Imaging 16(3):325–334
Ricchi P, Ammirabile M, Costantini S, Di Matola T, Verna R, Diano A, Foglia MC, Spasiano A, Cinque P, Prossomariti L (2012) A useful relationship between the presence of extramedullary erythropoeisis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients with thalassemia intermedia: a prospective study. Ann Hematol 91(6):905–909
Ricchi P, Ammirabile M, Spasiano A, Costantini S, Di Matola T, Pepe A, Cinque P, Pagano L, Casale M, Filosa A, Prossomariti L (2014) Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia. Blood Transfus 12(Suppl 1):s124–s130
Kim RJ, de Roos A, Fleck E, Higgins CB, Pohost GM, Prince M, Manning WJ (2007) Guidelines for training in cardiovascular magnetic resonance (CMR). J Cardiovasc Magn Reson 9(1):3–4
Meeks D, Navaratnarajah A, Drasar E, Jaffer O, Wilkins CJ, Thein SL, Sharpe CC (2017) Increased prevalence of renal cysts in patients with sickle cell disease. BMC Nephrol 18(1):298
Tanaka T, Nangaku M (2014) ANO1: an additional key player in cyst growth. Kidney Int 85(5):1007–1009
Semenza GL (2007) Life with oxygen. Science 318(5847):62–64
Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, Nilsson H, Pietras A, Vallon-Christersson J, Borg A, Gradin K, Poellinger L, Pahlman S (2006) Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10(5):413–423
Haase VH (2013) Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev 27(1):41–53
Motta I, Boiocchi L, Delbini P, Migone De Amicis M, Cassinerio E, Dondossola D, Rossi G, Cappellini MD (2016) A giant adrenal myelolipoma in a beta-thalassemia major patient: does ineffective erythropoiesis play a role? Am J Hematol 91(12):1281–1282
Ricchi P, Costantini S, Spasiano A, Di Matola T, Cinque P, Filosa A (2017) Myelolipoma among patients with thalassemia major and rare anemia with iron loading: a not so rare entity. Am J Hematol 92(3):E25–E26
Musallam KM, Taher AT (2012) Mechanisms of renal disease in beta-thalassemia. J Am Soc Nephrol 23(8):1299–1302
Bhandari S, Galanello R (2012) Renal aspects of thalassaemia a changing paradigm. Eur J Haematol 89(3):187–197
Acknowledgements
We would like to thank all the colleagues involved in the MIOT project (https://miot.ftgm.it/). We thank Claudia Santarlasci for her skillful secretarial work. We finally thank all patients for their cooperation.
Funding
The MIOT project receives “no-profit support” from industrial sponsorships (Chiesi Farmaceutici S.p.A. and ApoPharma Inc.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ricchi, P., Meloni, A., Grigoratos, C. et al. Prevalence of extramedullary hematopoiesis, renal cysts, splenic and hepatic lesions, and vertebral hemangiomas among thalassemic patients: a retrospective study from the Myocardial Iron Overload in Thalassemia (MIOT) network. Ann Hematol 98, 1333–1339 (2019). https://doi.org/10.1007/s00277-019-03659-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-019-03659-1